Guest EditorialInternational Journal of Pharmaceutical InvestigationVol. 1 | Issue 2 | pp. 62–63Open access
Mucoadhesion; A prerequisite or a constraint in nasal drug delivery?
- 1*
- 1 Department of Pharmaceutics, Rajiv Academy for Pharmacy, Mathura, Uttar Pradesh, INDIA.
Published in International Journal of Pharmaceutical Investigation
Correspondence: Kamla Pathak
Department of Pharmaceutics, Rajiv Academy for Pharmacy, Mathura, Uttar Pradesh, INDIA.
Email: kamla_rap@yahoo.co.in
- DOI:
- 10.4103/2230-973X.82383
How to cite
Pathak, K. Mucoadhesion; A prerequisite or a constraint in nasal drug delivery? International Journal of Pharmaceutical Investigation, 1(2), 62–63. https://doi.org/10.4103/2230-973X.82383
Abstract
Nasal drug administration has frequently been proposed as the most feasible alternative to parenteral injections. This is due to the high permeability of the nasal epithelium, allowing a higher molecular mass cut-off at approximately 1000 Da and the rapid drug absorption rate with plasma drug profiles sometimes almost identical to those from intravenous injections. Nasal drug administration is presently used for local therapies within the nasal cavity. Anti-allergic drugs and nasal decongestants are the most common examples. However, nasal drug administration for systemic effects has been practiced since ancient times. Nasallyadministered psychotropic drugs by native Indians, the use of tobacco snuffs, and nasal administration of illicit drugs such as cocaine are all well known.
Subject
Article metadata
| Title | Mucoadhesion; A prerequisite or a constraint in nasal drug delivery? |
|---|---|
| Authors | Kamla Pathak |
| Affiliations | Department of Pharmaceutics, Rajiv Academy for Pharmacy, Mathura, Uttar Pradesh, INDIA. |
| Corresponding author | kamla_rap@yahoo.co.in |
| Journal | International Journal of Pharmaceutical Investigation |
| Volume / Issue | Vol. 1, Issue 2 |
Also in this issue
- Nanopharmaceuticspp. 61
- Recent trends in vaccine delivery systems: A reviewpp. 64–74
- Developing micro-/nanoparticulate drug delivery systems using “design of experiments”pp. 75–87
- Preparation of poly(NIPAAm)-Pluronic F68 as a thermosensitive surfactant for a controlled drug releasepp. 88–92
- Effect of agar—gelatin compositions on the release of salbutamol tabletspp. 93–98